NEWS and RESOURCES​​​​​​​​​​​​

​

 

• AstraZeneca takes another China trip, picking Dizal’s lung cancer drug for up to $1.5B - by Tristan Manalac (7/14/26)

​

• AAIC 2026: Biogen delivers hope, validation with anti-tau Alzheimer’s win - by Heather McKenzie (7/14/26)

​

• Huyabio scores with Opdivo combo in 'milestone' skin cancer trial - by Kevin Dunleavy (7/14/26)

​

• Spero pivots to I&I with $1.1B deal for Innovent antibody, sells slice of Utebzi royalties for $105M - by Will Maddox (7/14/26)

​

• Cellares' recent automated cell therapy wins have 'opened the biotech floodgates' - by Fraiser Kansteiner (7/14/26)

​

​

Please contact us at nate@gloveportsolutions.com with any comments